A UK cannabis prescription is not a card, a recommendation or permission to buy cannabis from a retailer. It is a prescription for a specific medicine, issued through the UK prescribing system and dispensed by a pharmacy. An unlicensed CBPM must be supplied under the prescription or direction of a doctor on the GMC Specialist Register; licensed cannabis-based medicines follow their authorised prescribing rules.
Key takeaways
- A short checker can indicate that you may qualify, but it cannot make the prescribing decision.
- The clinician needs relevant medical-record information. In England, a Summary Care Record may help, but fuller GP records or specialist letters may still be needed.
- The specialist must assess clinical need, previous treatments, medicine interactions and risk factors.
- Initial unlicensed prescribing should generally receive appropriate peer review through an MDT or an equivalent governance process; the prescriber remains responsible.
- A pharmacy dispenses the medicine against the prescription and applies the dispensing label.
- Keep the medicine in its original packaging and retain prescription evidence.
What makes a cannabis prescription valid in the UK
Since 2018, it has been legal to prescribe cannabis-based products for medicinal use across the UK. The GMC explains that the supply of an unlicensed CBPM must be in accordance with the prescription or direction of a doctor on its Specialist Register. That doctor must work within their competence and have enough information to decide whether the medicine is appropriate for the individual patient.
This distinction matters because many cannabis-based products remain unlicensed. NICE recommendations cover particular products and clinical situations, but NHS England also states that the law does not restrict CBPM prescribing to a list of indications. A specialist still has to weigh the evidence, licensed alternatives, the patient’s history, likely risks and the specific clinical need. A diagnosis on its own does not decide suitability.
A GP does not usually initiate an unlicensed CBPM prescription. Shared care can be possible after specialist initiation if the clinicians agree a safe arrangement, but NHS England notes that the NHS will not normally take over shared care from a private prescriber for treatment that is not NHS commissioned. For most private patients, the specialist clinic retains prescribing and monitoring responsibility.
A practical way to understand the route
There is no single national six-step clinic process. Provider pathways vary, but safe care still needs relevant records, clinical assessment, appropriate governance, lawful pharmacy supply and monitoring. The stages below show how those safeguards commonly fit together.
1. First steer. A clinic form or the MCPH qualifying checker can help you understand whether you may qualify. It is triage, not a clinical decision.
2. Records. Ask what relevant medical-record information the clinician needs. In England, a Summary Care Record may help with medicines, allergies and adverse reactions, but the clinic may need fuller GP records or specialist letters for diagnosis and treatment history. Obtaining records is normally an administrative step, not a request for GP approval.
3. Specialist assessment. The specialist reviews symptoms, treatment history, current medicines, mental-health and substance-use history, physical-health risks, pregnancy or breastfeeding where relevant, and practical issues such as driving or work. Patients can discuss product forms or concerns, but the prescriber remains responsible for suitability, route and dose.
4. Clinical governance. Initial unlicensed prescribing should generally be peer-reviewed through an appropriately constituted multidisciplinary team or an equivalent, proportionate governance process. The prescribing clinician remains responsible and may decide that more information is needed or that prescribing is inappropriate.
5. Prescription and pharmacy. If treatment is agreed, the prescription goes to a pharmacy authorised to supply it. The pharmacy dispenses the exact prescribed item and provides the dispensing label and instructions. See how medical cannabis prescriptions are dispensed for the pharmacy stage.
6. Monitoring. The clinic should explain when review is due, who to contact about side effects and how any proposed change is assessed. Review timing depends on the patient, medicine and provider; it should be clear before treatment starts.
For a fuller walk-through, read how the UK prescription process works. If you are comparing private routes, check the medical cannabis cost guide before paying a first fee.
Proof of a prescription
The NHS advises patients to keep medicine in its original packaging because the dispensing label identifies the medicine and the person it was prescribed for. Keep a copy of the prescription and any prescriber letter you have, and carry matching identification when proof may be needed. Those documents do not remove the need to follow driving, travel or possession rules.
Speak to your prescriber or pharmacist if the label is unclear, the supplied item does not match what you expected, you experience side effects, or you are considering changing how the medicine is taken. Do not alter or replace a prescribed product using general online guidance.
Read next
- How the medical cannabis prescription process works in the UK
- How medical cannabis prescriptions are dispensed
- How to read a medical cannabis prescription label
- How to request your Summary Care Record
